120 related articles for article (PubMed ID: 16888619)
1. Loss of antibodies and response to (re-)vaccination in children after treatment for acute lymphocytic leukemia: a systematic review.
van Tilburg CM; Sanders EA; Rovers MM; Wolfs TF; Bierings MB
Leukemia; 2006 Oct; 20(10):1717-22. PubMed ID: 16888619
[TBL] [Abstract][Full Text] [Related]
2. Revaccination of children after completion of standard chemotherapy for acute leukemia.
Patel SR; Ortín M; Cohen BJ; Borrow R; Irving D; Sheldon J; Heath PT
Clin Infect Dis; 2007 Mar; 44(5):635-42. PubMed ID: 17278052
[TBL] [Abstract][Full Text] [Related]
3. Humoral immunity to diphtheria, tetanus, measles, and hemophilus influenzae type b in children with acute lymphoblastic leukemia and response to re-vaccination.
Zengin E; Sarper N
Pediatr Blood Cancer; 2009 Dec; 53(6):967-72. PubMed ID: 19544393
[TBL] [Abstract][Full Text] [Related]
4. Humoral immunity to tetanus, measles and rubella in children with acute lymphoblastic leukemia after chemotherapy.
Onorateli M; Botana C; Peralta L; Rebollo M; Ruvinsky S; Guitter M; Felice MS; Posadas M; Evangelista S; Villar MV; Golluscio M; Molina A; Fraquelli L
Arch Argent Pediatr; 2016 Dec; 114(6):549-552. PubMed ID: 27869413
[TBL] [Abstract][Full Text] [Related]
5. Assessment of immune response following immunization with DTP/Td and MMR vaccines in children treated for acute lymphoblastic leukemia.
Koochakzadeh L; Khosravi MH; Pourakbari B; Hosseinverdi S; Aghamohammadi A; Rezaei N
Pediatr Hematol Oncol; 2014 Oct; 31(7):656-63. PubMed ID: 25007393
[TBL] [Abstract][Full Text] [Related]
6. Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92.
Calaminus G; Hense B; Laws HJ; Groeger M; MacKenzie CR; Göbel U
Klin Padiatr; 2007; 219(6):355-60. PubMed ID: 18050047
[TBL] [Abstract][Full Text] [Related]
7. Protection against vaccine preventable diseases in children treated for acute lymphoblastic leukemia.
de de la Fuente Garcia I; Coïc L; Leclerc JM; Laverdière C; Rousseau C; Ovetchkine P; Tapiéro B
Pediatr Blood Cancer; 2017 Feb; 64(2):315-320. PubMed ID: 27718310
[TBL] [Abstract][Full Text] [Related]
8. Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines.
Paulke-Korinek M; Fischmeister G; Grac A; Rendi-Wagner P; Kundi M; Mohsenzadeh-Rabbani A; Moritz K; Fenninger B; Jarisch R; Jasinska J; Holzmann H; Wiedermann U; Kollaritsch H
Vaccine; 2011 Jul; 29(32):5130-6. PubMed ID: 21624412
[TBL] [Abstract][Full Text] [Related]
9. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
[TBL] [Abstract][Full Text] [Related]
10. Avidity of tetanus and Hib antibodies after childhood acute lymphoblastic leukaemia - implications for vaccination strategies.
Ek T; Mellander L; Hahn-Zoric M; Abrahamsson J
Acta Paediatr; 2006 Jun; 95(6):701-6. PubMed ID: 16754551
[TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.
Shinefield H; Black S; Thear M; Coury D; Reisinger K; Rothstein E; Xu J; Hartzel J; Evans B; Digilio L; Schödel F; Brown ML; Kuter B;
Pediatr Infect Dis J; 2006 Apr; 25(4):287-92. PubMed ID: 16567978
[TBL] [Abstract][Full Text] [Related]
12. Haemophilus influenzae type B in an immunocompetent, fully vaccinated ALL survivor.
Nevin J; Kanter Washko J; Arnold J
Pediatrics; 2013 May; 131(5):e1639-42. PubMed ID: 23589809
[TBL] [Abstract][Full Text] [Related]
13. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
[TBL] [Abstract][Full Text] [Related]
14. Revaccination of children with acute lymphoblastic leukemia following completion of chemotherapy.
Anafy A; Gilad G; Michaan N; Elhasid R; Rosenfeld-Kaidar H; Arad-Cohen N; Cohen MS; Shachor-Meyouhas Y; Grisaru-Soen G
Pediatr Blood Cancer; 2023 Jun; 70(6):e30321. PubMed ID: 37036274
[TBL] [Abstract][Full Text] [Related]
15. Measles, mumps, and rubella antibody status and response to immunization in children after therapy for acute lymphoblastic leukemia.
Aytac S; Yalcin SS; Cetin M; Yetgin S; Gumruk F; Tuncer M; Yurdakok K; Gurgey A
Pediatr Hematol Oncol; 2010 Aug; 27(5):333-43. PubMed ID: 20469978
[TBL] [Abstract][Full Text] [Related]
16. Antibody persistence against diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenzae type b (Hib) in 5-6-year-old children after primary vaccination and first booster with a pentavalent combined acellular pertussis vaccine: immunogenicity and tolerance of a tetravalent combined acellular pertussis vaccine given as a second booster.
Mallet E; Matisse N; Mathieu N; Langue J; Boisnard F; Soubeyrand B;
Vaccine; 2004 Mar; 22(11-12):1415-22. PubMed ID: 15063564
[TBL] [Abstract][Full Text] [Related]
17. Immunity to diphtheria, pertussis, tetanus, and poliomyelitis in children with acute lymphocytic leukemia after cessation of chemotherapy.
van der Does-van den Berg A; Hermans J; Nagel J; van Steenis G
Pediatrics; 1981 Feb; 67(2):222-9. PubMed ID: 6941208
[TBL] [Abstract][Full Text] [Related]
18. Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa).
Dhillon S
BioDrugs; 2010 Oct; 24(5):299-302. PubMed ID: 20795752
[TBL] [Abstract][Full Text] [Related]
19. Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation.
Patel SR; Ortín M; Cohen BJ; Borrow R; Irving D; Sheldon J; Heath PT
Clin Infect Dis; 2007 Mar; 44(5):625-34. PubMed ID: 17278051
[TBL] [Abstract][Full Text] [Related]
20. Antibody responses of healthy infants to concurrent administration of a bivalent haemophilus influenzae type b-hepatitis B vaccine with diphtheria-tetanus-pertussis, polio and measles-mumps-rubella vaccines.
West DJ; Rabalais GP; Watson B; Keyserling HL; Matthews H; Hesley TM
BioDrugs; 2001; 15(6):413-8. PubMed ID: 11520252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]